Skip to main content

Mahoney Michael F's Form 4 filing

Boston Scientific Corp (BSX) · filed Jun 3, 2025

Accession no.
0001225208-25-005681
Filed
Jun 3, 2025
Trade date
Jun 2, 2025
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $17.1M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Mahoney Michael FCIK 0001533022Director, Officer (Chairman, President & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 2, 2025Common StockMOption exerciseAcquired+56,212$17.26+$970,219.121,591,918Direct
Jun 2, 2025Common StockMOption exerciseAcquired+49,407$24.55+$1,212,941.851,641,325Direct
Jun 2, 2025Common StockSSaleDisposed−74,522$104.05−$7,754,014.11,566,803Direct
Jun 2, 2025Common StockSSaleDisposed−89,921$103.39−$9,296,932.191,476,882Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 2, 2025Common StockMOption exerciseDisposed−56,212$0.00$00Direct
Jun 2, 2025Common StockMOption exerciseDisposed−49,407$0.00$0148,221Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)